Skip to main content

Amicus Therapeutics, Inc.

FOLDDelisted Apr 27, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001178879

Amicus Therapeutics, Inc. was delisted on Apr 27, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 298 institutions reported holding it in 13F filings for Q1 2026, worth $4.81B in total; Soros Fund Management was the only superinvestor holding it.

Q2 2024 vs. Q1 2024

How the institutions holding Amicus Therapeutics, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of FOLD: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders2541259+6
Shares321.9M322.5K315.3M−6.32M (−2.0%)
Value$3.79B$3.80M$3.13B−$660.8M (−17.4%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (37)

Institutions that held Amicus Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to FOLD in Q2 2024
InstitutionSharesValue% of portfolio
Balyasny Asset Management LLC1,117,100$11.1M0.03%
Assenagon Asset Management S.A.845,407$8.39M0.02%
Essex Investment Management Co LLC268,000$2.66M0.50%
Mirae Asset Global ETFs Holdings Ltd.235,582$2.34M0.01%
Alps Advisors Inc231,037$2.29M0.02%
Corebridge Financial, Inc.157,857$1.57M0.01%
Connor, Clark & Lunn Investment Management Ltd.147,127$1.46M0.01%
Bank of Montreal107,369$1.10M0.00%
Algert Global LLC88,585$878.8K0.03%
Gsa Capital Partners LLP50,719$503.0K0.04%
Old West Investment Management, LLC47,465$470.9K0.21%
Twinbeech Capital LP34,145$338.7K0.01%
GTS Securities LLC22,647$224.7K0.00%
Caption Management, LLC21,900$217.2K0.02%
Oxford Asset Management LLP19,099$189.5K0.19%
Entropy Technologies, LP18,575$184.3K0.02%
Resources Investment Advisors, LLC.15,699$155.7K0.00%
Sanctuary Advisors, LLC13,445$138.2K0.00%
Brevan Howard Capital Management LP13,175$130.7K0.01%
Atria Investments LLC12,028$119.3K0.00%
Alpine Global Management, LLC11,297$112.1K0.02%
Bridgefront Capital, LLC10,983$109.0K0.05%
Sage Capital Advisors,llc10,400$103.2K0.03%
Omers Administration Corp10,300$102.2K0.00%
LPL Financial LLC10,096$100.2K0.00%
Headlands Technologies LLC8,947$88.8K0.01%
Optiver Holding B.V.3,273$32.5K0.00%
Clearstead Advisors, LLC2,076$20.6K0.00%
Quest Partners LLC2,058$20.4K0.00%
Ashton Thomas Private Wealth, LLC1,183$11.7K0.00%
Smartleaf Asset Management LLC900$8.92K0.00%
Hexagon Capital Partners LLC307$3.05K0.00%
Ronald Blue Trust, Inc.166$1.96K0.00%
Stephens Consulting, LLC189$1.88K0.00%
Itau Unibanco Holding S.A.177$1.76K0.00%
AdvisorNet Financial, Inc100$9920.00%
Innealta Capital, LLC47$4660.00%

Sold out (31)

Institutions that held Amicus Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Not filed for Q2 2024 yet (1)

Institutions that held Amicus Therapeutics, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding FOLD in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Credit Suisse AG322,544$3.80M